Lipigon Pharmaceuticals AB (OSTO:LPGO) Total Stockholders Equity : kr28.44 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Lipigon Pharmaceuticals AB Total Stockholders Equity?

Lipigon Pharmaceuticals AB's Total Stockholders Equity for the quarter that ended in Dec. 2023 was kr28.44 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Lipigon Pharmaceuticals AB's Book Value per Share for the quarter that ended in Dec. 2023 was kr0.22. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Lipigon Pharmaceuticals AB's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.00.

Lipigon Pharmaceuticals AB Total Stockholders Equity Historical Data

The historical data trend for Lipigon Pharmaceuticals AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipigon Pharmaceuticals AB Total Stockholders Equity Chart

Lipigon Pharmaceuticals AB Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

2.17

12.98

22.96

3.87

28.44

Lipigon Pharmaceuticals AB Quarterly Data
	Dec18	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial												13.07	3.87	27.59	22.72	28.44

Lipigon Pharmaceuticals AB (OSTO:LPGO) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Lipigon Pharmaceuticals AB's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(28.444	-	0)	/	126.422
	=	0.22

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Lipigon Pharmaceuticals AB's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	28.444
	=	0.00

Lipigon Pharmaceuticals AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Lipigon Pharmaceuticals AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lipigon Pharmaceuticals AB (OSTO:LPGO) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

9RP:Germany

Address

Tvistevagen 48 C, Umea, SWE, 90736

Website

https://www.lipigon.se

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Lipigon Pharmaceuticals AB (OSTO:LPGO) Headlines

No Headlines